Greater Cannabis Company (GCAN) Notes Payables (2016 - 2025)
Greater Cannabis Company (GCAN) recorded quarterly Notes Payables of $13775.0 in Q3 2025, down 2.7% quarter-over-quarter from $14157.0 in Q2 2025, and down 91.96% on a YoY basis from $171437.0 in Q3 2024.
Greater Cannabis Company (GCAN) Notes Payables (2016 - 2025) Analysis & Trends
Greater Cannabis Company's Notes Payables history runs 10 years deep, the most recent figure standing at $13775.0 for Q3 2025.
- In Q3 2025, Notes Payables fell 91.96% year-over-year to $13775.0; the TTM figure through Sep 2025 stood at $13775.0 (down 91.96% YoY), while the FY2024 annual figure was $171437.0, changed 0.0% from the prior year.
- Notes Payables was $13775.0 for Q3 2025 at Greater Cannabis Company, down from $14157.0 in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $467437.0 in Q1 2022 to a low of $13775.0 in Q3 2025.
- Historically, Notes Payables has averaged $163966.7 across 5 years, with a median of $171437.0 in 2023.
- The sharpest annual moves came in 2022 and 2025: Notes Payables surged 1977.5% in 2022, then slumped 91.96% in 2025.
- A 5-year view of Notes Payables shows it stood at $369095.0 in 2021, then slumped by 34.04% to $243437.0 in 2022, then fell by 29.58% to $171437.0 in 2023, then changed by 0.0% to $171437.0 in 2024, then sank by 91.96% to $13775.0 in 2025.
- The last three Notes Payables figures came in at $13775.0 (Q3 2025), $14157.0 (Q2 2025), and $111357.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Greater Cannabis Company | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 13,775.00 |
| Jun 30, 2025 | 14,157.00 |
| Mar 31, 2025 | 111,357.00 |
| Dec 31, 2024 | 171,437.00 |
| Sep 30, 2024 | 171,437.00 |
| Jun 30, 2024 | 171,437.00 |
| Mar 31, 2024 | 171,437.00 |
| Dec 31, 2023 | 171,437.00 |
| Sep 30, 2023 | 36,000.00 |
| Jun 30, 2023 | 243,437.00 |
| Mar 31, 2023 | 243,437.00 |
| Dec 31, 2022 | 243,437.00 |
| Sep 30, 2022 | 135,000.00 |
| Jun 30, 2022 | 25,000.00 |
| Mar 31, 2022 | 467,437.00 |
| Dec 31, 2021 | 369,095.00 |
| Sep 30, 2021 | 311,050.00 |
| Jun 30, 2021 | 22,500.00 |
| Mar 31, 2021 | 22,500.00 |
| Dec 31, 2020 | 22,875.00 |